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Bicarbonaturic effect of lysine in the dog. The infusion of 55
moles/kg/min of L-lysine monohydrochlonde increased mean
fractional bicarbonate excretion (CHc03/GFR) from 0.01 to 0.29.
This massive bicarbonaturia was observed in the absence of any
significant fall in GFR or kidney cortex AlP content. Kaliuresis
and urinary Pco2 also increased markedly while phosphaturia re-
mained minimal. CHCO3/GFR reached 0.52 during the infusion of
110 moles/kgImin of L-lysine monohydrochloride and 0.65
when carbonic anhydrase inhibition was superimposed. Bicar-
bonaturia remained minimal during the infusion of 55 moles/kg/
mm of L-lysine dihydrochioride. However the same amount of
isoelectric L-lysine and sodium L-lysinate increased CHcjGFR
to 0.68 and 0.76, respectively. In dogs with ligated renal pedicles,
a I I relationship was observed between cellular entry of lysine
and the combined shift of sodium and potassium from cell to ex-
tracellular fluid. Marked accumulation of lysine was observed in
the kidney following the infusion of either L-lysine mono-
hydrochloride or L-lysine dihydrochioride. This study demon-
strates that lysine inhibits in the proximal tubule the fraction of
bicarbonate reabsorption which is not mediated by carbonic an-
hydrase activity. This effect is best explained by trapping of hy-
drogen ions in the tubular cell following luminal and antiluminal
entry of lysine in unionized form. The possible role of lysine as a
poorly reabsorbable cation is also recognized.
Effet bicarbonaturique de Ia lysine chez le chien. L'admin-
istration par voie intraveineuse de 55 moles/kWmin de
monochiorhydrate de L-lysine fait augmenter l'excrétion frac-
tionnelle de bicarbonate (CHCO/GFR) de 0,01 a 0,29. Cette bicar-
bonatune massive est observée en l'absence de toute diminution
du debit de filtration glomérulaire ou du contenu cortical en
ATP. La kaliurêse et Ia Pco2 urinaire augmentent de facon im-
portante alors que Ia phosphaturie reste basse. CHCO.J/GFR atteint
0,52 au cours de Ia perfusion de 110 moles/kg/min de mono-
chlorhydrate de L-lysine et 0,65 quand l'inhibition de l'anhydrase
carbonique est surajoutée. La bicarbonaturie est minime au
cours de Ia perfusion de 55 moles/kg/min de dichlorhydrate de
L-lysine. Cependant Ia méme quantité de L-lysine isoClectriques
et de L-lysinate de sodium augmentent CHcfGFR jusqu'à 0,68
et 0,76, respectivement. Chez les chiens aux pédicules rénaux
lies, une relation I 1 est observée entre Ia pénCtration ccl-
lulaire de lysine et Ic transfert de sodium et de potassium de Ia
cellule au liquide extracellulaire. Une accumulation importante
de lysine est observée dans Ic rein aprés La perfusion de mono-
chlorhydrate de L-lysine ou de dichlorhydrate de L-lysine. Ce
travail démontre que Ia lysine inhibe, dans le tube proximal, Ia
reabsorption de Ia fraction du bicarbonate qui n'a pas
l'anhydrase carbonique pour médiateur. Cet effet peut être cx-
pliqué par Ia capture d'ions hydrogénes dans Ia cellule tubulaire
consecutive a l'entrée luminale et antiluminale de lysine sous
forme non ionique. Le role possible de La lysine en tant que cat-
ion peu réabsorbable est aussi reconnu.
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Although previous studies in the dog have dem-
onstrated that lysine infusion induced a striking bi-
carbonaturia [1, 2], changes in urinary acid-base pa-
rameters and electrolyte excretion have not been
extensively investigated. It has been suggested by
Walker, Dickerman, and Jost [I] that lysine acts as
intracellular proton acceptor and reduces hydrogen
ion secretion. In vitro studies with rat diaphragm
have shown that lysine replaces in a stoichiometri-
cally fashion intracellular potassium [3]. The present
experiments were undertaken in the dog to charac-
terize more precisely the effects of lysine on urinary
acid-base parameters and electrolyte excretion and
to determine whether or not lysine induces bicar-
bonaturia through a mechanism dependent on car-
bonic anhydrase. In order to exclude the renal ef-
fects of lysine infusion, studies have also been per-
formed after bilateral ligation of the renal pedicle.
Our data demonstrate that lysine infusion results in
massive bicarbonaturia, inhibiting the fraction of bi-
carbonate reabsorption which is not mediated by
carbonic anhydrase activity. This bicarbonaturia
was observed in the absence of any significant fail in
glomerular filtration rate or kidney cortex adenosine
triphosphate (ATP) content. In dogs with ligated
renal pedicles, a close relationship was observed
between cellular entry of lysine and the combined
shift of sodium and potassium from cell to extra-
cellular fluid.
Methods
Experimental procedures. Studies were per-
formed on 70 female mongrel dogs weighing be-
tween 13 and 28 kg (mean wt, 21 kg). Following an
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overnight fast, each dog was anesthetized with i.v.
sodium pentobarbital (30 mg/kg of body wt). Light
anesthesia was maintained with additional pento-
barbital as needed. A Harvard respirator was used
to ventilate the dogs mechanically through a cuffed
endotracheal tube. Ventilation was initially adjust-
ed to maintain arterial carbon dioxide tension
(Pco2) around 35 mm Hg. No further attempts were
made to prevent arterial Pco2 variations during the
remainder of the experiments.
Urine was collected under mineral oil through an
indwelling bladder catheter. Complete emptying of
the bladder was ensured by manual suprapubic
compression at the end of each collection period.
Each 20-mm clearance period was bracketed by ar-
terial blood samples drawn anaerobically through a
femoral artery indwelling catheter and analyzed im-
mediately for acid-base parameters. Following a
loading dose of creatinine (20 mg/kg of body wt), a
5% mannitol solution containing 2.5 g of creatinine
and 2 g ofp-aminohippurate (PAH) per liter was in-
fused in a femoral vein at the constant rate of 2 ml/
mm throughout each experiment. A period of at
least 90 mm was allowed to elapse before three con-
secutive control clearance periods were obtained
under stable urine flow. Following this control peri-
od, five different protocols were used.
Group I: Effect of L-lysine monohydrochloride in-
fusion. A 0.5 M solution of i-lysine monohydro-
chloride (highest purity, from Eastman Kodak
Co., Rochester, N.Y.) was infused during 180
mm at a dosage of 5 mg/kg/mm to four dogs and at a
dosage of 10 mg/kg/mm (55 jmoles/kg/min) to nine
other dogs. Over the course of the infusion, nine
consecutive 20-mm clearance periods were ob-
tained in each animal. Seven milliliters of 2 N sodium
hydroxide were used to adjust each liter of lysine
solution to a pH of 7.40. To rule out the possibility
that L-lysine monohydrochloride infusion de-
pressed bicarbonate reabsorption by expanding the
extracellular fluid volume, we infused four other
dogs with an equimolar amount of sodium chloride,
0.5 M.
Group 2: Effect of carbonic anhydrase inhibition
during L-lysine monohydrochloride infusion. Seven
dogs were given 20 mg/kg/mm (110 moles/kg/min)
of a 0.5 M neutralized solution of i-lysine mono-
hydrochloride during 240 mm. After 180 mm, maxi-
mal carbonic anhydrase inhibition was induced by a
priming dose of 20 mg of acetazolamide per kg of
body wt, followed by a maintenance dose of 20 mgI
kg/hr [41. In addition, four other dogs were infused
with 0.5 M sodium chloride in equimolar amounts
but did not receive acetazolamide.
Group 3: Effect of the infusion of other ionic
forms of L-lysine. Three groups of five dogs each
were given during 180 mm 55 1moles/kgImin of 0.5
M solutions of L-lysine dihydrochloride (pH, 1.0),
isoelectric L-lysine (pH, 9.8), and sodium L-lySinate
(pH, 12.2). L-Lysine dihydrochloride and isoelec-
tric i-lysine were prepared from i-lysine mono-
hydrochloride solution by adding equimolar
amounts of hydrochloric acid and sodium hydrox-
ide, respectively. Sodium L-lysinate was prepared
from i-lysine monohydrochloride solution by add-
ing twice the equimolar amount of sodium hydrox-
ide.
Group4: Effect of L-lysine ,nonohydrochloride in-
fusion after bilateral ligation of renal pedicles. This
protocol was designed to abolish urinary electrolyte
excretion and to exclude the renal effects of lysine
infusion. Following bilateral ligation of renal ped-
ides in II dogs, a 5% mannitol infusion (without
creatinine or PAH) at the rate of 2 mI/mm was
started 90 mm before drawing the first arterial blood
sample. Blood was also drawn at 20-mm intervals
during a 1-hr control period and throughout the
180-mm infusion of neutralized solution of L-lysine
monohydrochloride at a dosage of 55 moles/kgI
mm. Following bilateral ligation of renal pedicles,
four other dogs were given 55 moles/kg/min of 0.5
M sodium chloride instead of lysine.
Group 5: Tissue concentration of lysine following
L-lysine monohydrochioride or dihydrochloride in-
fusion. Following three control clearance periods,
tissue pieces from liver, right kidney, and sartorius
muscle of the right pelvic limb were obtained in 12
dogs by instantaneous freeze-clamping between two
aluminum blocks that had been previously cooled at
the temperature of liquid nitrogen according to the
technique of Wollenberger, Ristau, and Schoffa [5].
Right nephrectomy was performed immediately af-
ter obtention of kidney tissue. The dogs were then
infused with 0.5 M solution of L-lysine mono-
hydrochloride during 180 mm (eight dogs) or with L-
lysine dihydrochloride during 120 mm (four dogs) at
the rate of 55 moles/kgImin. As soon as the lysine
infusion was completed, tissue samples from liver,
remaining kidney, and sartorius muscle of the left
pelvic limb were freeze-clamped, and the animals
were killed.
The interval between removal of the tissue
sample and its freeze-clamping was always less than
5 sec. The measured tissue lactate/pyruvate ratio,
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taken as an index of the adequacy of this procedure
[6], was less than 20 in each sample. The frozen tis-
sues were pulverized and extracted with 6% wt/vol-
ume perchloric acid as described by Hems and
Brosnan [6]. Determination of adenine nucleotides
(adenosine triphosphate, adenosine diphosphate,
adenosine monophosphate), lactate, pyruvate, in-
organic phosphate, and lysine were performed on a
neutralized extract of deproteinized tissue.
Analytical methods. The pH of blood and urine
was determined anaerobically at 38° C with a pH
meter (Radiometer, model PHM 72). Analytical
methods used for determining carbon dioxide con-
tent, sodium, potassium, chloride, phosphate, and
creatinine concentrations have been described pre-
viously [7]. PAH concentration was measured by
the method of Bratton and Marshall as modified by
Smith et al [8]. L-Lysine concentration was deter-
mined manometrically on a Warburg apparatus with
L-lysine decarboxylase (purified powder of B. cada-
veris from Sigma Chemical Co., St. Louis, Mo.) ac-
cording to Gale [9]. Urinary citrate concentration
was determined with citrate lyase according to Dag-
ley [10]. Plasma and urine osmolalities were mea-
sured by freezing-point depression (Advanced In-
struments Osmometer). Adenine nucleotides (ATP,
ADP, AMP), lactate, and pyruvate concentrations
were determined by the same methods used by
Hems and Brosnan [6].
Calculations. Plasma carbon dioxide tension and
bicarbonate concentration were calculated from the
Henderson-Hasselbalch equation using a pK' of
6. 10 for carbonic acid and a solubility coefficient of
0.0301. A solubility factor of 0.0309 was used for
urine while the pK' was 6.33 — 0.5 V' (Nat) + (K),
with the concentrations of sodium and potassium
given in equivalents per liter [11]. Exogenous
creatinine clearance was used to measure glomeru-
lar filtration rate. PAH clearance (corrected for an
assumed extraction ratio of 0.75 [12] and hematocrit
were utilized to calculate renal blood flow. Concen-
trations of metabolites and lysine in tissues were
calculated in the same manner as that described by
Hems and Brosnan [6].
The external balance of ions was calculated as the
difference between the amount infused and the
combined output in urine and blood samples. To
calculate the concentrations of ions in extracellular
fluid (ECF), a Donnan factor of 0.95 was used for
sodium, potassium, and lysine, and a Donnan factor
of 1.05 was used for chloride and bicarbonate [13];
serum water was assumed equal to 0.93 gIml. Initial
ECF volume was assumed to be 20% of control
body weight. The external balance of chloride was
calculated in each 20-mm period as the difference
between the amount of chloride infused and the
combined loss of this anion in urine (when appli-
cable) and blood samples. These differences were
cumulated and added to the initial amount of chlo-
ride in the ECF. Chloride space was then calculated
backward from the amount of chloride in the ECF,
assuming that chloride was limited to this com-
partment; ECF volume was estimated from this cal-
culated chloride space [14, 15]. Shifts of sodium and
potassium between the extracellular and intra-
cellular phases were calculated in the usual fashion
[13, 16]. In dogs with bilateral ligation of the renal
pedicle, cellular entry of lysine was estimated as the
difference between the total amount of lysine in-
fused (plus the minimal amount already present in
ECF) and the lysine remaining in ECF at the end of
infusion. In the same animals, bicarbonate con-
sumption was estimated by subtracting the bicarbo-
nate calculated in the ECF at the end of lysine in-
fusion from that calculated during control period;
bicarbonate lost in blood samples was taken into ac-
count.
Unless otherwise specified, the term significant is
used throughout the paper to describe a difference
which has a P value of less than 0.05 as determined
by Student's t test for paired data.
Results
Group I: Effect of L—lvsine inonohydrochloride in-
fusion. In dogs given 5 mg/kg/mm of L-lysine mono-
hydrochloride, fractional bicarbonate excretion in-
creased only slightly and in a nonsignificant fashion
from 0.01 to 0.05. By contrast, the infusion of 10
mg/kg/mm (55 moles/kg/min) of i-lysine mono-
hydrochloride induced a striking bicarbonaturia,
mean fractional bicarbonate excretion (CHc./GFR)
rising from 0.01 to 0.29 within 120 mm after the on-
set of infusion and remaining constant during the
next 60 mm (Fig. 1). It should be noted that the bi-
carbonaturic effect of lysine was not abolished by
the progressive metabolic acidosis (Table I) result-
ing from the mean cumulative bicarbonaturia of 31
mEq. Mean bicarbonaturia was more important
than natriuresis, and a marked increment in urinary
Pco2 was observed (Table I).
Urinary potassium excretion also increased
markedly, mean fractional excretion reaching 0.82
(Table 2). The mean cumulative kaliuresis of 29
mEq represented 73% of the potassium calculated
to have been shifted from the cells during lysine in-
fusion. Indeed, total shift of sodium and potassium
from intracellular to extracellular fluid averaged 47
and 40 mEq, respectively (Table 3). Mean plasma
potassium concentration rose progressively from
3.2 to 5.4 mEqlliter, whereas the reduction in
plasma sodium concentration averaged 8 mEqlliter
(Table 1).
Plasma concentration of both chloride and lysine
rose progressively during L-lysine monohydro-
chloride infusion (Table 1). The increased fil-
tered load of lysine resulted in a rise in its fractional
excretion from 0.02 to 0.78, whereas lysine reab-
sorption averaged 125 p.moles/min during lysine in-
fusion. Plasma phosphate concentration remained
stable and urinary excretion minimal during lysine
infusion. Mean glomerular filtration rate decreased
by only 12% at the end of lysine infusion, while re-
nal blood flow fell significantly by 29% (Table 1).
In four other dogs that were infused with equimo-
lar amounts of sodium chloride, fractional bicarbo-
nate excretion did not exceed 0.04 (Table 2) al-
though the rise in extracellular fluid volume was
much more important than in lysine-infused dogs
(Table 3). In these experiments, fractional excretion
of potassium remained virtually unchanged and
fractional phosphate excretion rose from 0.04 to
0.26. Glomerular filtration rate increased slightly
from 78 to 86 mI/mm, and renal blood flow in-
creased from 398 to 435 mllmin. A significant
amount of potassium shifted from intracellular to
extracellular fluid, whereas no net movement of so-
dium was observed between these two phases
(Table 3).
Group 2: Effect of carbonic anhydrase inhibition
during L-lysine monohydrochioride infusion. The
infusion of 110 Lmoles/kg/min of L-lysine mono-
hydrochloride increased markedly the mean frac-
tional bicarbonate excretion, which stabilized at
0.52 120 mm after the start of infusion (Fig. 2). Note
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Fig. 1. Effect of L-lysine monohydrochioride infusion (55 unoles/
kg/mm) on fractional bicarbonate excretion (means SEM).
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Fig. 2.Additive effect of carbonic anhydrase inhibition (CAl) on
fractional bicarbonate excretion during continuous infusion of
110 pinoles/kg/min of i-lysine monohydrochioride (means
SEM).
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Table!. Effect of L-lysine monohydrochioride in the doga
Lysine infusion, 55 moles/kg/min
Control 20mm 60mm 120mm 180mm
Blood pH 7.38 0.01 7.37 0.01 7.34 001" 7.31 0,01b 7.24 0,01b
Plasmabicarbonate,mEq/liter 22.1 0.7 21.6 0.5 20.2 0.4" 16.7 04b 14.0 0.6'
Arterial Pco2,mm Hg 39.1 0.3 38.8 0.6 38.5 1.2 34.1 12" 33.3 12"
Plasmasodium,mEq/liter 144.0 1.0 141.3 0.9" 139.2 0•8b 137.0 0.7" 136.0 0.8"
Plasmapotassium,mEq/liter 3.2 0.1 3.7 0.1" 4.4 0.1" 4.7 0.2" 5.4 0.1"
Plasma lysine, mM/liter 0.5 0.1 3.1 0.2" 6.8 1.1" 10.1 1,2b 10.4 0.7"
Plasmachloride,mEq/Iiter 105.9 1.1 108.2 1,3" 111.7 1.4" 118.2 1.8" 121.2 1.6"
Plasmaphosphate,mM//iter 1.2 0.1 1.2 0.1 1.3 0.1 1.2 0.1 1.3 0.1
Plasmaosmolality,mOsm/kg 313 4 315 5 318 5 323 5" 323 4"
Urine flow, mI/mm 1.1 0.1 1.9 0.2" 2.9 0.2" 4,5 0.5' 4,7 0,3"
Urine pH 6.96 0.15 7.29 0.06" 7.26 0.06 7.31 0.04" 7.21 0.04
Urine Pco2, mm Hg 48.5 2.7 69.1 3.1" 106.0 9.0" 129.8 9.0" 133.6 8.5"
UH0,V,pEq/min 14.1 3.7 50.7 7.1" 111.9 25.0" 240.1 35.5" 212.9 25.2"
UNaV,uEq/min 36.4 10.5 53.6 11.2 31.5 8.1 108.1 27.4" 125.0 23.9"
UV,pEq/min 26.3 4.8 34.7 4.2" 87.3 14.1" 222.2 30.1" 241.1 23.7"
U,ys,neV,,uM/min 0.8 0.3 78.3 8.0" 223.0 13.5" 308.2 19.2" 445.5 32.8"
U,V,p.Eq/min 24.8 7.3 98.3 15.1" 243.1 35.0" 453.0 678" 639.3 55.9'
U0,V,pM/min 0.7 0.2 0.8 0.4 2.0 0.7 3.8 1.3" 5.0 1.7'
Urine osmolality,mOsm/kg 818 96 647 66" 589 70" 506 53b 585 52"
GFR,mI/min 64.7 5.8 69.5 6.0 62.3 4.7 54.6 4.4 56.9 3.7
RBF,mI/min 464.5 68.8 498.1 76.9 345.3 48.9" 337.6 65.4 331.2 51.7"
Values are means SEM (N = 9). Abbreviations used are: Pco2, carbon dioxide tension; and UV, urinary excretion of solute de-
noted by subscript (HCO3, bicarbonate; Na, sodium; K, potassium; Cl, chloride; P04, phosphate).
"A significant difference from control value (P < 0.05).
Table 2. Fractional electrolyte excretion dataa
CHco,/GFR C0/GFR C,IGFR CiystneJGFR CK/GFR CNa/GFR
Control 0.009 0.002 0.010 0003 0.003 0.001 0.023 0.007 0.120 0.013 0.004 0.001
L-lysine monohydrochloride,
55 pM/kg/min (N = 9) 0.287 0.051" 0.060 0.021" 0.094 0.008" 0.781 0.048" 0.823 0.089" 0.017 0.003"
Control 0.006 0.004 0.039 0.017 0.003 0.001 — 0.169 0.053 0.003 0.001
Sodium chloride,
55 tM/kg/min (N = 4) 0.035 0.012 0.255 0.050" 0.025 0.008 — 0.196 0.021 0.025 0.007'
Control 0.008 0.003 0.025 0.012 0.010 0.004 0.047 0.009 0.175 0.031 0.008 0.003
L-lysine monohydrochloride,
l10M/kWmin 0.518 0.066" 0.043 0.022 0.273 0.034" 0.884 0.098" 1.082 0.173" 0.071 0.016"
L-lysine monohydrochlonde +
acetazolamide(N = 7) 0.649 0.038' 0.076 0.036 0.277 0.029 0.633 0.050' 1.245 0.129 0.055 0.015
Control 0008 0.005 0.017 0.011 0.002 0.001 — 0.142 0.051 0.003 0.002
Sodium chloride,
l10M/kg/min(N = 4) 0.066 0.026 0.317 0.019" 0.106 0,023" — 0.528 0.130" 0.079 0.018"
Control 0.033 0.009 0.016 0.005 0.013 0.005 0.058 0.031 0.191 0.025 0.013 0.005
L-lysine dihydrochloride,
55 LM/kg/min (N = 5) 0.019 0.006 0.427 0,023b 0.130 0.010" 0.597 0.038" 0.575 0.112' 0.028 0.007
Control 0.018 0.006 0.013 0.006 0.007 0.002 0.020 0.003 0.164 0.030 0.007 0.002
Isoelectric L-lysine,
55 iM/kg/min (N = 5) 0.683 0.036" 0.017 0.006 0.072 0008" 0.885 0.115" 1.013 0.101" 0.084 0.005"
Control 0.003 0.001 0.004 0.002 0.002 0.001 0.007 0.004 0.122 0.024 0.001 0.001
Sodium L-Iysinate,
55 LM/kg/min (N = 5) 0.762 0.085" 0.009 0.009 0.095 0.036 0.887 0.071" 1.825 0.198" 0.166 0.042"
a Values are means sEM. These are control values and values observed after 180 mm of lysine (or sodium chloride) infusion or 60
mm of acetazolamide. Abbreviations used are: C, clearance of bicarbonate (HCO3), phosphate (P04), chloride (Cl), potassium (K), and
sodium (Na).
"A significant difference from control value (P < 0.05).
'Significantly different from lysine alone (P < 0.05).
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Table 3. Changes in chloride space and shifts of sodium and potassium from intracellular to extracellular space after 180 mm of L-Iysine
or sodium chloride infusion3
Chloride space
% of control value
Sodium s
pnEq
hift Potassium shift
mEq
L-lysinemonohydrochlonde,55/LM/kg/min(N = 9) 106.2 11b
Sodium chloride, 55 M/kWmin (N = 4) 116.1 04b
47•3
3.0
30b
3.8
39.6 3.9"
13.8 2.9"
1-lysine monohydrochloride, 110 /ZM/kg/min (N = 7) 112.0 15b
Sodium chloride, 110M/kWmin(N = 4) 129.7 33b
85.3
—27.3
8.3"
10.6
56.1 7.8"
29.3 2.5"
L-lysine dihydrochloride, 55 M/kg/min (N = 5) 116.0 0•6b
IsoeIectncL-lysine,55.LM/kg/min(N = 5) 106.5 1.5"
SodiumL-lysinate,55M/kg/min(N = 5) 108.7 3.6
132.5
—5.6
—134.4
8.0"
5.8
18.6"
74.2 3.2"
36.4 4.6"
31.7 5.8"
After bilateral ligation of renal pedicles
L-lysine monohydrochloride, 55 LM/kg/min (N = 11) 124.9 0.6"
Sodium chloride, 55 aM/kg/min (N = 4) 125.6 1.3"
54.1
—0.5
52b
3.6
26.9 3.1"
12.3 2.6b
a Values are means SEM.
b Indicates a significant change (P < 0.05) by comparison with control values taken as 0 (or 100% for chloride space).
that mean urinary citrate excretion increased from a
control value of 0.085 to 0.474 mo1e/min despite
the progressive metabolic acidosis of extracellular
fluid resulting from lysine infusion. Kaliuresis be-
came massive (Table 4) and exceeded the amount of
potassium filtered within 80 mm after the onset of
lysine infusion. The 39-mEq mean kaliuresis repre-
sented 70% of the potassium calculated to have
been shifted from intracellular to extracellular fluid
during lysine infusion. Changes in plasma sodium,
potassium, chloride, and lysine concentrations
were similar but quantitatively more important than
in group 1. Plasma phosphate concentration, how-
ever, remained essentially unchanged and urinary
phosphate excretion minimal (Table 4).
Carbonic anhydrase inhibition during lysine in-
fusion was followed by a further and significant rise
in mean fractional bicarbonate excretion, which in-
creased from a stable value of 0.52 to 0.65 (Fig. 2
and Table 2) despite the important metabolic acido-
sis (Table 4). Urinary potassium excretion ex-
ceeded by 25% the amount filtered, whereas
phosphaturia remained negligible (Table 4). Frac-
tional lysine excretion decreased significantly from
0.88 to 0.63 (Table 2), whereas its reabsorption rose
from 70 to 276 j.moles/min.
In four other dogs, the administration of equimo-
lar amounts of sodium chloride increased extra-
cellular fluid volume markedly (Table 3), but frac-
tional bicarbonate excretion did not exceed 0.07
(Table 2). Both fractional potassium and phosphate
excretion rose significantly (Table 2). Glomerular
filtration rate increased from 71 to 102 mllmin, and
renal blood flow increased from 381 to 488 mlimin.
Group 3: Effect of the infusion of other ionic
forms of L-lysine. The infusion of L-lysine dihy-
drochioride resulted in a rapid and severe fall in
both blood pH and plasma bicarbonate concentra-
tion (Table 5). Mean fractional bicarbonate excre-
tion remained virtually unchanged throughout ly-
sine infusion (Table 2). Plasma potassium concen-
tration rose markedly from 3.1 to 7.7 mEq/liter,
whereas fractional potassium excretion increased to
0.58. The mean cumulative kaliuresis of 33 mEq
represented only 44% of the potassium shifted from
cell during lysine infusion. Plasma sodium concen-
tration fell significantly, while plasma phosphate
concentration remained stable (Table 5). Note that,
by contrast with all other groups of dogs given ly-
sine, fractional phosphate excretion rose markedly
(Table 2). Fractional lysine excretion remained
around 0.60, and lysine reabsorption averaged 188
j.moles/min during lysine infusion. Plasma lysine
concentration reached 16.2 mmoles/liter, a value
higher than in the three other groups of dogs given
55 moles/kgImin of lysine. Both glomerular filtra-
tion rate and renal blood flow had fallen by 40% at
the end of lysine infusion.
Plasma acid-base parameters remained essen-
tially unchanged throughout the infusion of isoelec-
tric L-lysine (Table 5) which induced massive bicar-
bonaturia, mean fractional bicarbonate excretion
increasing from 0.02 to 0.68 (Table 2). Mean urinary
citrate excretion increased from a control value of
0.106 to 0.830 mole/min at the end of lysine in-
fusion. Plasma potassium concentration rose only
to 4.3 mEq/liter, and urinary potassium excretion
was virtually identical to the amount filtered (Table
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Table 4. Effect of L-lysine monohydrochioride in the intact dog and during carbonic anhydrase inhibitiona
2). The 30-mEq kaliuresis represented 82% of the
potassium leaving the cells during lysine infusion. It
is noteworthy that, in the absence of change in ex-
tracellular acid-base composition, no shift of so-
dium between intracellular and extracellular fluid
was observed. Plasma phosphate concentration de-
creased significantly, while phosphaturia remained
minimal. Mean lysine reabsorption was 58 .tmoles/
mm during lysine infusion. Glomerular filtration
rate decreased by 40%, and renal blood flow de-
creased by 45%.
The infusion of sodium L-lysinate induced a meta-
bolic alkalosis (Table 5) and increased mean frac-
tional bicarbonate excretion from 0.003 to 0.76
(Table 2). Although plasma potassium concentra-
tion remained stable throughout the study, mean
fractional potassium excretion reached 1.83 (Table
2). The 29-mEq kaliuresis represented 91% of the
potassium shifted from the cells during lysinate in-
fusion, while 134 mEq of sodium were shifted from
extracellular to intracellular fluid. Plasma phos-
phate concentration fell markedly to 0.4 moleIli-
ter, and phosphaturia remained minimal. Lysine
reabsorption averaged 53 mmoles/min during lysi-
Lysine infusion,
Control 20 mm 60 mm
110 moles/kg/min
Acetazolamide
(lysine continued)
120 mm 180 mm 200 mm 240 mm
BloodpH 7.36 7.35 7.31 7.22 7.11 7.08 7.04
0.01 0.01 0,01b 0.01" 0.01" 0.01 0.02'
Plasmabicarbonate,mEq/liter 20.0 19.8 17.4 13.1 10.9 11.6 10.8
0.3 0.3 0,5b 05b 04b 0.5 0.6
Arterial Pco,, mm Hg 36.3
0.5
37.3
1.2
35.4
1.2
32.9
1.3"
35.3
1.3
40.0
2.4e
41.2
2.5C
Plasma sodium, mEqiliter 144.1
0.5
140.5
0.7"
137.8
1.0"
134.3
1.8"
130.9
1.9"
130.6
1.8
127.2
1.7c
Plasma potassium, mEqiliter 3.1
0.2
3.7
0.2"
4.7
0.3"
5.8
0.2"
6.8
0.2"
6.7
0.2
7.1
0.3
Plasma lysine, mM/liter 0.4
0.1
5.5
05b
12.1
0.8"
18.4
2.6"
20.8
33b
26.8
3.6c
31.6
4,5e
Plasma chloride, mEq/liter 109.5
0.9
114.1
1.0"
120.8
1.2"
129.7
1.9"
135.6
2.2"
137.0
2.7
140.1
2.9e
Plasma phosphate, miIliter 1.2
0.1
1.3
0.1
1.3
0.1
1.2
0.2
1.2
0.2
1.2
0.2
1.4
0.1
Plasma osmolality, mOsm/kg 314 329 341 352 357 370 373
Urine fiow,ml/min 1.6
0.6
3.4
07b
6.0
0.8"
8.6
1.2"
8.0
13b
7.9
1.2
6.8
1.3
UnnepH 6.62
0.20
7.19
004"
7.25
0.06"
7.25
001b
7.08
002b
7.16
O.0l'
7.12
0.01
Urine Pco2,mm Hg 45.6
5.3
74.8
7•5
97.6
98b
111.9
145b
107.2
8.2"
112.2
9.4
120.4
11.0
UHCO,V, p.Eq/min 8.6
3,3
67.5
110b
212.2
48.1"
317.7
33.2"
205.3
352b
268.3
53.0
220.0
48.5
U5aV, p.Eq/min 61.1
22.6
70.2
17.0
164.3
51.7
360.6
78.5"
360.6
105.9"
364.3
107.1
255.9
89.3
UV,pEq/min 31.7
5.1
55.4
14.6
166.7
341b
288.1
46.8"
253.1
48.5"
301.4
5l.5c
269.0
58.6
UiysjneV, /.LM/min 1.4
0.5
188.4
23.0"
525.6
766b
740.1
107.6"
660.4
1245b
700.5
136.3
567.2
130.5
Uc,V,p.Eq/min 58.5
23.4
269.0
349b
602.3
62.4"
1331.9
1582b
1331.0
239.5"
1256.8
220.7'
1154.4
236.4
U0V, /.LM/min 2.5
1.2
2.9
1.8
2.7
1.3
2.5
1.3
3.2
2.0
3.5
2.0
5.0
2.6
Urine osmolality, mOsm/kg 909
294
464
101
308
50
342
59
389
66
343
44
358
42
GFR,ml/min 63.4
7.3
67.7
8.0
47.5
6,Øb
49.3 39.5
74b
37.9
7,3
33.1
7.3'
RBF, mI/mm 460.2
69.0
449.3
69.3
301.8
30.9"
328.5
57.3
268.0
53.0"
254.2
58.9
223.9
56.Se
a Values are means SEM (N = 7). See Table I for definition of abbreviations.
"A significant difference from control value (P < 0.05).
Significantly different from lysine alone at 180 mm (P < 0.05).
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TableS. Effect of other ionic forms of L-lysine (55 LM/kgImin) in the doga
L-Lysine dihydrochloride Isoelectric L-lysine Sodium L-lySiflate
Control Lysine Control Lysine Control Lysine
Blood pH 7.40 0.01 6.68 0.06" 7.40 0.01 7.40 0.02 7.36 0.02 7.53 0.03"
Plasma bicarbonate,mEq/!iter 21.0 0.9 3.9 0.1" 21.2 0.2 22.6 0.6 19.8 1.1 38.2 1.7"
ArterialPco2,mmHg 35.1 0.8 34.9 3.1 35.7 0.8 37.4 1.6 36.5 1.9 48.1 4.9
Plasma sodium,mEqlliter 143.4 0.8 130.2 1.5" 143.6 1.8 150.7 1.7" 142.6 2.0 165.7 0.7"
Plasma potassium,mEq/Iiter 3.1 0.2 7.7 0.3" 3.1 0.1 4.3 0.2" 2.9 0.2 2.9 0.2
Plasma lysine, mM/liter 0.4 0.03 16.2 1.2" 0.4 0.1 11.3 1.4" 0.3 0.1 12.5 1.1"
Plasma chloride. ,zEqIliter 108.9 1.4 137.7 1.0" 107.3 1.6 125.6 l.8" 107.1 1.6 125.0 1.7"
Plasma phosphate, ,nsc/liter 1.0 0.1 1.2 0.1 1.2 0.1 0.9 0.1" 1.0 0.2 0.4 0.1"
Urinefiow,ml/min 1.7 0.3 4.1 1.4 1.5 0.2 5.0 0.5" 1.0 0.2 6.0 2.2
Urine pH 7.31 0.17 5.54 0.20" 6.99 0.31 7.63 0.02 6.28 0.15 7.81 0.03"
UrinePco2,mmllg 50.9 5.8 81.3 12.6 46.4 2.5 140.4 13.5" 55.2 7.0 101.2 14.9"
GFR,ml/min 69.6 8.4 42.8 12.5 71.7 9.6 43.9 5.8" 71.4 8.2 29.3 11.1"
RBF,m!/min 450.9 57.2 278.7 92.2 486.3 92.7 269.7 24.7 502.0 72.4 276.1 90.4
a Values are means SEM (N = 5). These are control values and values observed after 180 minutes of lysine infusion.
"A significant difference from control value (P < 0.05).
nate infusion. Glomerular filtration rate had fallen cellular space resulted in a marked rise in plasma
by 60%, and renal blood flow had fallen by 45%at potassium concentration from 3.3 to 7.9 mEq/liter.
the end of the infusion. A I : I linear relationship was observed between
Group 4: Effect of L-lysine monohydroch/oride in- cellular entry of lysine and total cation shift to ex-
fusion after bilateral ligation of renal pedicles. The tracellular fluid (Fig. 3).
infusion of i-lysine monohydrochloride resulted in In dogs given sodium chloride, plasma bicarbo-
a 6-mEq/liter reduction in mean plasma bicarbonate nate concentration fell only slightly from 20.8 to
concentration (Table 6) in the absence of any 19.7 mEq/liter despite identical degree of extra-
change in plasma Pco2. Only 5.8 mEq of extra- cellular volume expansion (Table 3). There was no
cellular bicarbonate were calculated to have been significant shift of sodium between intracellular and
consumed during lysine infusion. Intracellular to extracellular phases, while the amount of potassium
extracellular sodium shift averaging 54 mEq did not shifted from cell to extracellular fluid averaged 12
prevent a 22-mEq/liter fall in mean plasma sodium mEq.
concentration (Table 6), which is best attributed to Group 5: Tissue concentration oflysinefollots'ing
the 25% increase in extracellular fluid volume. A 27- L-lysine monohydrochloride or dihydrochloride in-
mEq shift of potassium from intracellular to extra- fusion. The infusion of i-lysine monohydrochloride
Table 6. Effect of L-lysine monohydrochloride (55 M/kg/min) in the dog after bilateral ligation of renal pediclesa
Lysine infusion
Control 20mm 60mm 120mm 180mm
Blood pH 7.40 0.01 7.38 0.01" 7.35 0.01" 7.30 0.01" 7.27 0.01"
Plasma bicarbonate, mEqiliter 21.6 0.6 20.5 0.5" 19.4 0.6" 17.9 0.6" 15.7 0.6"
Arterial Pco2, mm Hg 36.0 1.0 35.6 0.9 36.2 1.0 37.8 1.4 35.3 1.4
Plasma sodium, mEq/liter 138.8 1.5 134.9 1.5" 130.3 1.5" 122.4 1.4" 116.8 1.5"
Plasma potassium,mEq/liter 3.3 0.2 3.7 0.2" 4.9 0.3" 6.9 0.4" 7.9 0.4"
Plasma lysine, m,'.I/!iler 0.4 0.1 3.5 0.1" 8.5 0.3" 16.8 0.9" 23.3 1.0"
Plasma chloride, mEqiliter 102.8 1.5 103.6 1.6" 106.2 1.7" 108.9 1.9" 113.1 1.9"
Plasma phosphate, mM/liter 1.4 0.1 1.5 0.1" 1.6 0.1" 1.5 0.1 1.3 0.1
Plasma osmolality. mOsm/kg 291 3 296 2 303 3" 313 3" 320 2"
ECFvolume./iters 3.73 0.35 3.84 0.35" 4.05 0.37" 4.38 0.39" 4.64 0.42"
Sodium shift to ECF,'nEq — 5.0 1.5" 20.6 l.5" 39.6 2.7" 54.1 5.2"
Potassium shift to ECF,mEq — 2.1 0.3" 8.4 1.5" 19.3 2.4" 26.9 3.1"
a Values are means SEM (N = II).
"A significant difference from control value (P < 0.05).
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resulted in changes in plasma and urinary acid-base
parameters and electrolyte concentration which
were similar to those observed in group 1. The rise
in plasma potassium concentration to 6.7 mEq!Iiter
was, however, greater than in group 1. Glomerular
filtration rate fell from 95 to 41 mI/mm 180 mm after
right nephrectomy. It should be noted that striking
accumulation of lysine was observed in both kidney
and liver (Table 7). Although a tenfold increase was
noted in muscle, the concentration of lysine in this
tissue remained lower than in plasma (Table 7). Ly-
sine infusion induced no significant change in kid-
ney, liver, and muscle adenine nucleotides and in-
organic phosphate concentration, except a 18% fall
in liver phosphate (Table 7).
The infusion of L-lysine dihydrochloride induced
no significant change in kidney, liver, and muscle
adenine nucleotides and inorganic phosphate con-
centrations with the exception of a 25% rise in liver
ATP (Table 7). It is noteworthy that, even if marked
accumulation of lysine took place in kidney tissue
(Table 7), bicarbonaturia remained minimal in these
animals as previously described in group 3.
Discussion
The present study demonstrates that lysine in-
fusion, in the absence of any significant fall in gb-
merular filtration rate, can divert into the urine 30%
of the filtered bicarbonate. With larger doses, tubu-
lar rejection of bicarbonate exceeds 50% in spite of
metabolic acidosis. As much as 68% of the filtered
bicarbonate is excreted in the urine when the in-
fusion of isoelectric lysine prevents the develop-
ment of acidosis. No significant change in kidney
cortex ATP content was noted following lysine in-
fusion. These observations contrast with those
made with maleate administration, in which bicar-
bonaturia is associated with a marked fall in gb-
merular filtration rate [71 and reduced ATP content
in the renal cortex [171.
Extracellular fluid volume expansion cannot ac-
count for the massive lysine-induced bicarbona-
tuna. Indeed, the infusion of an equimolar amount
of sodium chloride increases fractional bicarbonate
excretion only slightly and to a value comparable to
that calculated from data reported by others [18,
19]. In addition, the bicarbonaturia observed during
lysine infusion cannot be explained by the mannitol
infused since it has previously been established in
this laboratory that a similar amount of mannitol
does not divert more than 2% of the filtered bicarbo-
nate into the urine [71.
It is noteworthy that lysine-induced bicarbona-
tuna exceeds sodium excretion by far. In some ex-
periments, bicarbonaturia was accompanied by
minimal natriuresis and even exceeded by far the
combined natriuresis and kaliuresis. This dis-
sociation between the bicarbonaturic effect of by-
sine and sodium excretion argues against bicarbo-
nate loss in relation to primary inhibition of sodium
reabsorption.
During lysine infusion, fractional bicarbonate ex-
cretion can further be increased by maximal car-
bonic anhydrase inhibition, in spite of important
metabolic acidosis, a condition well-known to re-
duce the bicarbonaturic effect of acetazolamide
[20]. The important fraction of bicarbonate reab-
sorption not mediated by carbonic anhydrase activi-
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N= 44
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Fig. 3. Relationship between cellular entry of lysine and ca lion
shift to extracellular fluid. The regression lines were calculated
by the method of least squares.
224 Gougoux et al
Table 7. Adenine nucleotides, phosphate, and lysine in tissues before and after the infusion of 55 LM/kg/min of L-lysine
monohydrochloride (180 mm) or dihydrochlonde (120 min)a
Control
(N=8)
L-lysine
monohydrochioride(N=8)
Control(N=4)
L-lysifle
dihydrochioride(N=4)
Kidney
ATP 1.76 0.10 1.49 0.09 1.96 0.12 1.56 0.21
ADP 1.41 0.10 1.30 0.07 0.89 0.03 0.89 0.09
AMP 0.32 0.05 0.34 0.06 0.28 0.04 0.35 0.07
Phosphate 2.85 0.43 3.06 0.28 2.85 0.22 3.15 0.22
Lysine 0.30 0.10 27.94 2.66' 0.12 0.07 34.25 1,90b
Liver
ATP 2.70 0.18 2.62 0.10 2.49 0.22 3.11 0•18b
ADP 1.74 0.18 1.89 0.03 0.98 0.07 1.02 0.11
AMP 0.44 0.05 0.54 0.09 0.41 0.04 0.34 0.03
Phosphate 4.45 0.22 3.64 026b 4.15 0.46 3.95 0.36
Lysine 0.45 0.15 27.66 2.60k 0.28 0.28 23.08 234b
Muscle
ATP 5.16 0.17 5.10 0.28 5.99 0.32 5.79 0.17
ADP 1.98 0.12 2.23 0.16 0.78 0.03 0.70 0.03
AMP 0.04 0.02 0.06 0.03 0.11 0.03 0.11 0.02
Phosphate 10.96 0.83 10.28 0.39 11.05 0.57 10.58 0.91
Lysine 0.43 0.14 4.78 0.64" 0.14 0.14 5.35 0.67"
Plasma
Phosphate, mM/liter 1.50 0.08 1.55 0.14 1.33 0.21 1.38 0.21
Lysine, PflM/liter 0.30 0.05 10.48 1.36" 0.48 0.12 17.85 1•18b
Except for plasma, results are expressed as mo1e/g wet weight, and values are means SEM.
A significant difference from control value (P < 0.05).
ty [21] is therefore inhibited at least in part by ly-
sine. This additive effect of lysine and acetazola-
mide agrees with in vitro studies in which lysine
failed to inhibit carbonic anhydrase activity [1]. One
cannot, however, exclude with certainty the possi-
bility that lysine had already inhibited in part car-
bonic anhydrase activity in our in vivo study.
Tubular rejection of bicarbonate observed in the
present study is of such magnitude that lysine must
inhibit proximal reabsorption of bicarbonate. The
marked accumulation of lysine in renal tissue ob-
served in our study is comparable to that reported
by others in rat kidney cortex slices [22, 23]. It
seems reasonable to suggest that lysine accumu-
lated mostly in proximal tubular cells because both
stop-flow studies in dogs [24, 25] and tubular micro-
injection experiments in rats [26] have shown proxi-
mal reabsorption of this amino acid.
Most of the intracellular lysine should exist in
cationic form since its pK'2 value is 8.95 [27]. Intra-
cellular accumulation of cationic lysine could de-
crease the potential difference across the pen-
tubular cell membrane and consequently reduce the
favorable electrochemical gradient for passive dif-
fusion of bicarbonate out of the proximal cell. As an
alternate possibility, hydrogen ion secretion from
proximal cell to tubular lumen might be reduced
through trapping of intracellular protons by accu-
mulating lysine if, as suggested by Walker et al [1],
lysine enters the cell in its unionized form. Alkalini-
zation of renal tubular cell is supported by in-
creased urinary citrate excretion [28], which oc-
curred despite metabolic acidosis, a condition well-
known to reduce citratunia [29]. That lysine dihy-
drochloride infusion had little effect on bicarbonate
excretion despite marked accumulation of lysine in
renal tissue is best accounted for by the striking fall
in plasma bicarbonate concentration and con-
sequently in its filtered load.
Studies suggest that lysine is transported mainly
in its cationic form across the membrane of Ehrlich
cell [30] or the brush border of the proximal tubular
cell [31]. As proposed by Walker et al [1], however,
lysine could enter the cell in its unionized form.
Transport of lysine at the luminal site would leave a
proton in tubular fluid but in much smaller amount
that the filtered bicarbonate. For example, at a
plasma bicarbonate concentration of 14 mEq/liter
and a glomerular filtration rate of 55 mI/mm, the 125
moles of lysine reabsorbed per minute (a value
slightly higher than the Tm of 103 moles/min pre-
viously reported at comparable plasma lysine con-
centration [32] and the release of an identical
amount of protons in tubular fluid could neutralize
only 16% of filtered bicarbonate. It is realized that
lysine, like glutamine [12], leucine, and arginine
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[33], can also enter the renal cell at the antiluminal
site [34]. Since this could be a passive phenomenon,
it is not known whether lysine could leave protons
in the peritubular capillaries, which could explain in
part the metabolic acidosis resulting from lysine
monohydrochloride and dihydrochloride infusion.
An alternative hypothesis deserving consid-
eration is that lysine, existing mostly in cationic
form in tubular fluid, simply behaves as a poorly
reabsorbable cation which forces the excretion of bi-
carbonate and chloride to maintain electroneutrali-
ty. Indeed, marked lysinuria is observed in the pres-
ent studies because the reabsorptive capacity for ly-
sine is limited. The major difficulty in this
hypothesis arises from the fact that the combined
excretion of chloride and bicarbonate is two times
as great as that of lysine.
The rapid and striking rise in urinary Pco2 during
lysine infusion suggests that the distal mechanism
responsible for secretion of protons remains intact
[35, 36]. Proton release from intraluminal non-
bicarbonate buffers during alkalinization of tubular
fluid could also increase urinary Pco2 [37]. In the
presence of minimal phosphaturia, the rise ob-
served in the present study cannot be attributed to
back titration of phosphate. Furthermore, proton
release resulting from dissociation of cationic lysine
in tubular lumen could account for no more than
34% of the observed rise in urinary Pco2, even if
tubular fluid were alkalinized from a value of 6.8 in
the collecting duct to a final value of 7.21 in the
urine (calculations done with data from the last peri-
od in group 1).
It should be pointed out, however, that the strik-
ing rise in urinary Pco2 observed during lysine in-
fusion was much greater than the modest increase
in this parameter recently reported by Arruda et a!
[38] in bicarbonate-loaded dogs. The possibility that
in our study lysine reabsorption in its unionized
form might have contributed to this difference can-
not be excluded. Such reabsorption in the proximal
tubule could release significant amounts of protons
in the lumen and consequently increase proximal
tubular fluid Pco2. This view is consistent with the
high Pco2 recently found in proximal tubular fluid
both in in vivo [39] and in in vitro [40] studies.
In contrast to the massive bicarbonaturia we re-
cently observed with maleate [7], there was com-
plete dissociation between the marked bicarbona-
turia and the minimal phosphaturia observed during
lysine infusion. The absence of significant phospha-
tuna in the presence of urinary alkalinization con-
trasts sharply with the usual parallelism observed
between urinary excretion of phosphate and bi-
carbonate [41, 42]. Since monovalent phosphate
(H2P04) is reabsorbed selectively over divalent
phosphate (HPO4=) [43], lysine-induced alkaliniza-
tion of intratubular fluid, by shifting the equilibrium
of the buffer pair in favor of divalent phosphate,
should favor phosphate excretion, a phenomenon
which was not observed in the present study. The
greater phosphaturia observed during sodium chlo-
ride than during lysine monohydrochloride infusion
can probably be accounted for by extracellular vol-
ume expansion, a factor well-known to increase
phosphaturia [44, 45].
A striking rise in urinary potassium excretion was
noted during lysine infusion. Intracellular renal ac-
cumulation of lysine in cationic form could reduce
net proximal reabsorption of potassium from lumen
to renal tubular cell through modification of poten-
tial difference between cell and lumen. In addition,
distal secretion of potassium is believed to be accel-
erated by alkaline tubular fluid [46]. Such a mecha-
nism was suggested to explain renal potassium
wasting in patients with proximal renal tubular aci-
dosis [47]. The release of potassium from extrarenal
cells with a rise in plasma potassium concentration
certainly contributed to increase kaliuresis. It
should be noted, however, that during sodium lysi-
nate infusion an unequivocal net renal secretion of
potassium was observed in the presence of a stable
plasma potassium concentration.
Since lysine can replace intracellular potassium
stoichiometrically as a cation [3], the release of po-
tassium from the cell accounts for the progressive
rise in plasma potassium concentration during ly-
sine monohydrochloride infusion. A similar rise has
also been observed following the administration of
other cationic amino acids, such as arginine and or-
nithine [48]. It should be noted that, as already re-
ported [15], sodium chloride infusion also induced a
significant but smaller shift of potassium from cell
to extracellular fluid. The well-known relationship
between the degree of extracellular acidosis and
plasma potassium concentration [49] can account
for no more than 40% of the observed rise in plasma
potassium concentration by the end of infusion of
lysine monohydrochloride. Furthermore, plasma
potassium concentration rose significantly during
the infusion of isoelectric lysine, which kept blood
pH stable throughout the procedure.
In the experiments performed in dogs with ligated
pedicles, lysine entry into cells was three times
greater than the release of potassium into extra-
cellular fluid. These findings contrast sharply with
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the 1 : 1 relationship between muscle lysine content
and decrease in muscle potassium observed in rat
diaphragms incubated in Krebs-Ringer solution at a
pH of 7.4 [3]. In our study, the shift of sodium from
cell to extracellular fluid was two times greater than
that of potassium. This discrepancy between in vitro
and our in vivo studies is best explained by the
metabolic acidosis observed in vivo, a condition
well-known to induce a greater shift of sodium than
of potassium from intracellular to extracellular
compartment [14, 50]. In fact, in our study, a 1: 1
relationship was observed between the amount of
lysine entering the cell and the combined shift of
sodium and potassium to extracellular fluid.
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